2016
DOI: 10.18632/oncotarget.11092
|View full text |Cite
|
Sign up to set email alerts
|

Systematic identification of immunodominant CD4+ T cell responses to HpaA inHelicobacter pyloriinfected individuals

Abstract: In mice, antigen-specific CD4+ T cell response is indispensible for the protective immunity against Helicobacter pylori (H. pylori). It has been demonstrated that neuraminyllactose-binding hemagglutinin (HpaA) immunization protected mice from H. pylori infection in a CD4+ T cell dependent manner. However, much remains unclear concerning the human CD4+ T cell responses to HpaA. We conducted a systematic study here to explore the immunodominant, HpaA-specific CD4+ T cell responses in H. pylori infected individua… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2017
2017
2019
2019

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 38 publications
(46 reference statements)
0
12
0
Order By: Relevance
“…Although some previous studies on H. pylori -specific Th1 cell responses focused on specific antigens, they did not identify individual epitopes and therefore were not aware of the influence of involved HLA (D'Elios et al, 1997b , 2003 ). Recently, many scientists began to pay attention to identifying HLA-restricted CD4 + T cell epitopes of H. pylori protective antigens using overlapping synthetic peptides, such as UreB 373−385 and UreB 438−452 (Yang et al, 2013 ), HpaA 88−100 and HpaA 142−159 (Chen et al, 2013 ; Hu et al, 2016 ). Chen et al found that the HpaA 88−100 -specific Th1-polarized response in H. pylori -infected subjects was linked with resistance to severe H. pylori- associated gastric diseases (Chen et al, 2013 ).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Although some previous studies on H. pylori -specific Th1 cell responses focused on specific antigens, they did not identify individual epitopes and therefore were not aware of the influence of involved HLA (D'Elios et al, 1997b , 2003 ). Recently, many scientists began to pay attention to identifying HLA-restricted CD4 + T cell epitopes of H. pylori protective antigens using overlapping synthetic peptides, such as UreB 373−385 and UreB 438−452 (Yang et al, 2013 ), HpaA 88−100 and HpaA 142−159 (Chen et al, 2013 ; Hu et al, 2016 ). Chen et al found that the HpaA 88−100 -specific Th1-polarized response in H. pylori -infected subjects was linked with resistance to severe H. pylori- associated gastric diseases (Chen et al, 2013 ).…”
Section: Discussionmentioning
confidence: 99%
“…Although several immunodominant epitopes of H. pylori protective antigens were identified (Chen et al, 2013 ; Yang et al, 2013 ; Li et al, 2015 ; Hu et al, 2016 ), much remains unclear concerning CD4 + T cell response to many H. pylori antigens. Our previous studies constructed an epitope vaccine based on our identified two Lpp20 H-2 d restricted CD4 + T cell epitopes (Li et al, 2012 ), which stimulated prophylactic and therapeutic responses with Th1-type profile against H. pylori in mice (Li et al, 2015 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Several groups investigated Helicobacter vaccines using mouse models, however, very few tested their protective efficacy. The most commonly investigated vaccine antigens were urease B, neuraminyllactose‐binding hemagglutinin (HpaA), and H. pylori whole cells or lysates …”
Section: Vaccinesmentioning
confidence: 99%
“…[41][42][43] Several groups investigated Helicobacter vaccines using mouse models, however, very few tested their protective efficacy. The most commonly investigated vaccine antigens were urease B, 44,45 neuraminyllactose-binding hemagglutinin (HpaA), [46][47][48] and H. pylori whole cells or lysates. 49,50 Several different adjuvants were used in the published studies, but as in previous years, the most common was cholera toxin B subunit.…”
Section: Immunization and Vaccinesmentioning
confidence: 99%